These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28805757)
1. [The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV; Scuderi A; Antignani PL Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):28-35. PubMed ID: 28805757 [TBL] [Abstract][Full Text] [Related]
2. [Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Proshin AN Antibiot Khimioter; 2014; 59(7-8):30-6. PubMed ID: 25975105 [TBL] [Abstract][Full Text] [Related]
3. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Kartashova EA; Romantsov MG; Sarvilina IV Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853 [TBL] [Abstract][Full Text] [Related]
4. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928 [TBL] [Abstract][Full Text] [Related]
5. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033 [TBL] [Abstract][Full Text] [Related]
7. Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow. Bul'on VV; Krylova IB; Evdokimova NR; Kovalenko AL; Alekseeva LE; Sapronov NS Bull Exp Biol Med; 2004 Apr; 137(4):411-4. PubMed ID: 15452617 [TBL] [Abstract][Full Text] [Related]
8. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
9. [The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension]. Kartashova EA; Romantsov MG; Sarvilina IV Eksp Klin Farmakol; 2014; 77(6):18-23. PubMed ID: 25102730 [TBL] [Abstract][Full Text] [Related]
10. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA]. Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922 [TBL] [Abstract][Full Text] [Related]
11. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma]. Deriugina AV; Shumilova AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087 [TBL] [Abstract][Full Text] [Related]
12. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.]. Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432 [TBL] [Abstract][Full Text] [Related]
13. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]. Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423 [TBL] [Abstract][Full Text] [Related]
14. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286 [TBL] [Abstract][Full Text] [Related]
15. [STRESS-PROTECTIVE EFFECT OF CYTOFLAVIN ON CHRONIC CEREBRAL ISCHEMIA IN RATS.]. Krylov VN; Deryugina AV; Antipenko EA Eksp Klin Farmakol; 2016; 79(9):29-32. PubMed ID: 29787669 [TBL] [Abstract][Full Text] [Related]
16. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615 [TBL] [Abstract][Full Text] [Related]
18. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
19. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency]. Beĭn BN; Dravert NE Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]